Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
暂无分享,去创建一个
T. Wileman | C. Philpott | A. Pratas | Ekta Sharma | L. Luke | Allan B. Clark | J. Mattock | A. Espehana | J. Gavrilovic | S. Gokani
[1] M. Kanakis,et al. Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review , 2022, International forum of allergy & rhinology.
[2] G. Wang,et al. Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence , 2022, International Immunopharmacology.
[3] A. Bhalla,et al. Vitamin D and Interleukins in Chronic Rhinosinusitis with Polyposis , 2022, Indian Journal of Otolaryngology and Head & Neck Surgery.
[4] Jianbo Shi,et al. Association Between Serum Amyloid A Expression and Disease Control after Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis With Nasal Polyps. , 2021, Ear, nose, & throat journal.
[5] Hua Zhang,et al. The role of serum macrophage migration inhibitory factor in preoperative prediction of chronic rhinosinusitis with nasal polyps endotypes. , 2021, International immunopharmacology.
[6] Yu-Tsai Lin,et al. JAK2 Phosphorylation Signals and Their Associated Cytokines Involved in Chronic Rhinosinusitis with Nasal Polyps and Correlated with Disease Severity , 2021, Biomolecules.
[7] W. Kong,et al. Role of P2X7R in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps , 2021, Molecular medicine reports.
[8] S. Vaitkus,et al. Chronic Rhinosinusitis with Nasal Polyps: Age and Disease Severity Differences in the Levels of Inflammatory Markers , 2021, Medicina.
[9] Timothy L. Smith,et al. Olfactory cleft mucus inflammatory proteins in CRS: a case‐control study , 2021, International forum of allergy & rhinology.
[10] A. Hamdan,et al. Evaluation of Serum Total Immunoglobulin E, Interleukin-17 and Pentraxin-3 as Biomarkers for Chronic Rhinosinusitis With Nasal Polyposis , 2020, American journal of rhinology & allergy.
[11] A. Peters,et al. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. , 2020, The Journal of allergy and clinical immunology.
[12] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.
[13] Ara Jo,et al. Enhanced Type 2 Immune Reactions by Increased IL-22/IL-22Ra1 Signaling in Chronic Rhinosinusitis With Nasal Polyps , 2020, Allergy, asthma & immunology research.
[14] A. Crăciun,et al. Biochemical markers of inflammatory syndrome in chronic rhinosinusitis , 2020, Romanian Biotechnological Letters.
[15] Seung-Heon Shin,et al. Nasal Epithelial Cells Activated with Alternaria and House Dust Mite Induce Not Only Th2 but Also Th1 Immune Responses , 2020, International journal of molecular sciences.
[16] Chengshuo Wang,et al. Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma , 2020, Clinical and Translational Allergy.
[17] Seung‐Kyu Chung,et al. Age‐associated changes in chronic rhinosinusitis endotypes , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] Chuling Li,et al. Interleukin-33 Promotes Th2/Th17 Response in Eosinophilic and Non-Eosinophilic Nasal Polyps , 2019, ORL.
[19] Su-Jin Shin,et al. Diverse phenotypes and endotypes of fungus balls caused by mixed bacterial colonization in chronic rhinosinusitis , 2019, International forum of allergy & rhinology.
[20] Joseph K. Han,et al. Establishing Urinary Leukotriene E4 as a Diagnostic Biomarker for Chronic Rhinosinusitis with Comorbid Asthma and Atopy , 2019, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[21] H. Lou,et al. Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. , 2019, The Journal of allergy and clinical immunology.
[22] H. Kojima,et al. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps. , 2019, Auris, nasus, larynx.
[23] Seung‐Kyu Chung,et al. Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries , 2019, Allergy, asthma & immunology research.
[24] C. Hopkins,et al. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care , 2019, BMJ Open.
[25] Dong‐Kyu Kim,et al. Chronic Rhinosinusitis without Nasal Polyps in Asian Patients Shows Mixed Inflammatory Patterns and Neutrophil-Related Disease Severity , 2019, Mediators of inflammation.
[26] Naweed I Chowdhury,et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms , 2018, International forum of allergy & rhinology.
[27] Yun Ma,et al. Interleukin‐4‒induced posttranscriptional gene regulation of CCL26 by the RNA‐binding protein HuR in primary human nasal polyp‒derived epithelial cells , 2018, International forum of allergy & rhinology.
[28] Huabin Li,et al. Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma. , 2018, Journal of thoracic disease.
[29] Dae Woo Kim,et al. Comparison Between Signature Cytokines of Nasal Tissues in Subtypes of Chronic Rhinosinusitis , 2018, Allergy, asthma & immunology research.
[30] Yoo La Lee,et al. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis , 2018, Front. Immunol..
[31] C. Bachert,et al. Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL‐5‐positive chronic rhinosinusitis with nasal polyps , 2018, Allergy.
[32] M. Kohanski,et al. Biomarkers in Chronic Rhinosinusitis with Nasal Polyps. , 2018, Immunology and allergy clinics of North America.
[33] S. Zheng,et al. Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis , 2018, Front. Immunol..
[34] Da-Wei Li,et al. Pro‐inflammatory role of transient receptor potential canonical channel 6 in the pathogenesis of chronic rhinosinusitis with nasal polyps , 2018, International forum of allergy & rhinology.
[35] Huabin Li,et al. Differential Hrd1 Expression and B-Cell Accumulation in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis With Nasal Polyps , 2018, Allergy, asthma & immunology research.
[36] Kristine A. Smith,et al. Calgranulin C (S100A12) Is Differentially Expressed in Subtypes of Chronic Rhinosinusitis , 2018, American journal of rhinology & allergy.
[37] Dong‐Kyu Kim,et al. Two-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis , 2018, Allergy, asthma & immunology research.
[38] Shukla Das,et al. Serum Cytokine Profile in Patients with Chronic Rhinosinusitis with Nasal Polyposis Infected by Aspergillus flavus , 2017, Annals of laboratory medicine.
[39] Geng Xu,et al. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[40] Dae Woo Kim,et al. Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine , 2017, Allergy, asthma & immunology research.
[41] Sohee Oh,et al. The role of interleukin-33 in chronic rhinosinusitis , 2016, Thorax.
[42] C. Bachert,et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. , 2016, The Journal of allergy and clinical immunology.
[43] Zheng Liu,et al. Distinct mucosal immunopathologic profiles in atopic and nonatopic chronic rhinosinusitis without nasal polyps in Central China , 2016, International forum of allergy & rhinology.
[44] C. Bachert,et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. , 2016, The Journal of allergy and clinical immunology.
[45] M. Gröger,et al. Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys , 2016, Allergy, Asthma & Clinical Immunology.
[46] J. Mo,et al. Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps , 2016, PloS one.
[47] C. Philpott,et al. Chronic rhinosinusitis: patient experiences of primary and secondary care – a qualitative study , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[48] Z. Soler,et al. Reduced sinonasal levels of 1α‐hydroxylase are associated with worse quality of life in chronic rhinosinusitis with nasal polyps , 2016, International forum of allergy & rhinology.
[49] E. Magen,et al. Anticytokine autoantibodies in chronic rhinosinusitis. , 2015, Allergy and asthma proceedings.
[50] Hyun-Woo Shin,et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. , 2015, The Journal of allergy and clinical immunology.
[51] Hanson Lu,et al. Serum levels of specific IgE to Staphylococcus aureus enterotoxins in patients with chronic rhinosinusitis , 2015, Experimental and therapeutic medicine.
[52] Shi Yu,et al. Increased IL‐21 expression in chronic rhinosinusitis with nasalpolyps , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[53] Chien‐Ho Chen,et al. Serum Level of Interleukin-21 is Elevated in Chronic Rhinosinusitis , 2015, American journal of rhinology & allergy.
[54] C. Bachert,et al. Mixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps , 2014, PloS one.
[55] Luo Zhang,et al. The Expression of Epithelial Intercellular Junctional Proteins in the Sinonasal Tissue of Subjects with Chronic Rhinosinusitis: A Histopathologic Study , 2014, ORL.
[56] C. Bachert,et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. , 2013, The Journal of allergy and clinical immunology.
[57] A. Peters,et al. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. , 2013, The Journal of allergy and clinical immunology.
[58] E. Banoglu,et al. Serum interleukin‐16 levels in patients with nasal polyposis , 2012, The Laryngoscope.
[59] J Bousquet,et al. Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.
[60] H. Stammberger,et al. Released intranasal eosinophilic major basic protein as a diagnostic marker for polypoid chronic rhinosinusitis , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[61] C. Bachert,et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. , 2010, The Journal of allergy and clinical immunology.
[62] A. Peters,et al. Rhinitis , sinusitis , and upper airway disease Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps , 2022 .
[63] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[64] C. Bachert,et al. Differential expression of the interleukin 5 receptor α isoforms in blood and tissue eosinophils of nasal polyp patients , 2009, Allergy.
[65] Xiang Lu,et al. Clara cell 10‐kDa protein expression in chronic rhinosinusitis and its cytokine‐driven regulation in sinonasal mucosa , 2009, Allergy.
[66] C. Bachert,et al. Local immunoglobulin production in nasal polyposis is modulated by superantigens , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[67] V. Lund,et al. The Lund-Mackay staging system for chronic rhinosinusitis: How is it used and what does it predict? , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[68] C. Bachert,et al. Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis , 2006, Respiratory research.
[69] J. Pearson,et al. Major Secretory Mucin Expression in Chronic Sinusitis , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[70] A. Falus,et al. The Pathogenesis of Nasal Polyposis by Immunoglobulin E and Interleukin‐5 Is Completed by Transforming Growth Factor‐β1 , 2003, The Laryngoscope.
[71] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[72] R. Metson,et al. Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[73] Christopher F. Thompson,et al. Proton pump inhibitors decrease eotaxin‐3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K‐ATPase , 2017, The Journal of allergy and clinical immunology.
[74] M. Yılmaz,et al. The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps , 2016, European Archives of Oto-Rhino-Laryngology.